Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  thymidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-23 of 23 for your search:
Start Over
Phase III Randomized, Placebo-Controlled Study of Oral Thymidine for the Prevention of Mucositis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/98)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 to 90
Sponsor: NCI
Protocol IDs: CHNMC-IRB-90014, NCI-V96-1043
Phase III Comparison of 5-FU vs 5-FU/PALA vs 5-FU/LEV vs 5-FU/MeCCNU/VCR/SZC vs 5-FU/TdR for Unresectable or Metastatic Colorectal Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-804651, MAYO-804651, NCCTG-80-46-51
Phase I/II Chemotherapy with ARA-C plus TdR Given by Continuous Infusion in Patients with Acute Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7911
Phase I/II Chemotherapy with High-Dose ARA-C plus Biochemical Modulation with PALA/Thymidine in Patients with CML in Blast Crisis and Relapsed Acute Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8433, NCI-T84-0418D, T84-0418
Phase II Study of Thymidine and Carboplatin in Patients with Recurrent Malignant Glioma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NABTC-9705
Phase II Hepatic Infusion Therapy with FUDR, MTX/TDR, NZS, ADR, BCNU, DCM for Primary or Metastatic Liver Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: DFCI-76050
Phase II Combination Chemotherapy with Methotrexate/Thymidine for Metastatic or Unresectable Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: DFCI-77044
Phase II Chemotherapy with PALA/TDR/5-FU for Advanced Dukes D Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: MDA-DT-8133
Phase II Chemotherapy with PALA/5-FU/TdR for Measurable Metastatic or Recurrent Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-824601, NCI-W82-1367, W82-1367
Phase II Chemotherapy with PALA/TDR/5-FU for Advanced Measurable Anaplastic Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-844851, MAYO-844851, NCCTG-84-48-51
Phase II Chemotherapy with High-Dose MTX with TDR Rescue in Children and Adolescents with Metastatic and Unresectable Osteosarcoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-MTX-THY, NCI-T84-0511D, T84-0511
Phase II Chemotherapy with PALA/TDR/5-FU in Patients with Advanced Diffuse Mixed or Large Cell non-Hodgkin's Lymphoma Who Have Failed Primary Treatment
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-857851, MAYO-857851, NCCTG-85-78-51
Phase II Study of DTIC/BCNU in Combination with Thymidine in Patients with Metastatic Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 16
Sponsor: NCI
Protocol IDs: YALE-HIC-7078, NCI-T93-0129D, T93-0129
Phase I Combination Chemotherapy with TdR/PALA/5-FU for Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-W80-0566
Phase I Evaluation of Combination Chemotherapy with TdR/ARA-C and TdR/ARA-C/PALA for Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-W80-0426
Phase I Trial of Thymidine and CACP in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMC-1594
Phase I Analysis of the Concept of "Early" Thymidine Protection in Methotrexate Therapy
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MCV-DMO-283, NCI-T83-0863D, T83-0863
Phase I Trial of Thymidine and CACP in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: UCCRC-4115, NCI-T83-1141W, T83-1141
Phase I Pilot Study of BCNU plus Thymidine in Patients with Advanced Malignancies (Summary Last Modified 12/90)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: YALE-HIC-4693, NCI-T88-0060D, T88-0060
Phase I Study of Intravenous Thymidine and CBDCA in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9193, NCI-T91-0161H, T91-0161
Phase I Chemotherapy with TDR/ARA-C for Leukemia or Unresectable Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-W80-0160
Study of Carboxypeptidase-G2 and Thymidine in Patients With Methotrexate Toxicity Secondary to Renal Dysfunction (Summary Last Modified 03/2001)
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-92-C-0134F, NCI-T92-0022N, T92-0022
Start Over